If you are a Healthcare Professional and you would like to log in to access this content, please click "Login".
You are now leaving the Lilly Medical Web site
Please use a minimum of three unique search wordsOur search is configured to only display links relevant to answer your question. For the best results please use specific and relevant keywords that accurately reflect the information you are seeking.Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at UK: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
Taltz ® (ixekizumab)
This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. Please refer to the link for full prescribing information:
Taltz Summary of Product Characteristics (SmPC)
Taltz® (ixekizumab): Missed Dose in patients with Psoriatic Arthritis
The Taltz European Summary of Product Characteristics does not contain a specific recommendation about what to do when a patient forgets a dose of ixekizumab.
US Taltz package insert states that if a dose is missed, the dose
should be administered as soon as possible. Thereafter, resume
dosing at the regular scheduled time.1
the ixekizumab clinical development program, ixekizumab was
administered at approximately the same time each day, as much as
the pivotal SPIRIT PsA clinical trials, injections not administered
on the scheduled day were to be administered
3 to 4 days of the scheduled day from week 0 to week 24, and
4 to 5 days of the scheduled day after week 24.3
alone or in combination with methotrexate, is indicated for the
treatment of active psoriatic arthritis in adult patients who have
responded inadequately to, or who are intolerant to one or more
disease-modifying anti-rheumatic drug (DMARD) therapies.4
Taltz [package insert]. Indianapolis, IN: Eli Lilly and Company;